Acurx Pharmaceuticals, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Submission of Matters to a Vote of Security Holders

Material Modifications to Rights of Security Holders

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

2.02,9.01

5.07

2.02,9.01

2.02,9.01

1.01,9.01

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Registration (IPO) statement under Securities Act of 1933

Rule 506(b) provides a "safer harbor" for a private offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Prospectus Supplement for Primary Offering

Registration (IPO) statement under Securities Act of 1933

Notice of Effectiveness

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Shawah Robert G.

Sailer Carl

DEAN JACK H

Donohue James J.

HARRISON THOMAS L

Scodari Joseph C

DELUCCIA ROBERT J

LUCI DAVID P

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC

DELUCCIA ROBERT J

Shawah Robert G.

LUCI DAVID P

DEAN JACK H

Sailer Carl

LUCI DAVID P

Scodari Joseph C

Donohue James J.

DELUCCIA ROBERT J

Sailer Carl

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC